Downregulated IRS-1 and PPARγ in obese women with gestational diabetes: relationship to FFA during pregnancy
- 1 March 2002
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 282 (3) , E522-E533
- https://doi.org/10.1152/ajpendo.00124.2001
Abstract
Gestational diabetes mellitus (GDM) is associated with elevated postprandial free fatty acids (FFA) and insulin resistance; however, little is known about the cellular mechanisms underlying insulin resistance to suppress lipolysis during gestation. We evaluated the longitudinal changes in insulin suppression of FFA before pregnancy and in early (12–14 wk) and late (34–36 wk) gestation in obese subjects with normal glucose tolerance and in obese GDM subjects. Abdominal subcutaneous adipose tissue biopsies were also obtained during cesarean delivery from normal obese pregnant (Preg-Con), GDM, and nonpregnant obese control (Non-Preg-Con) subjects during gynecological surgery. GDM subjects had higher basal plasma FFA before pregnancy ( P = 0.055). Insulin's ability to suppress FFA levels declined from early to late gestation in both GDM and Preg-Con subjects and was significantly less in GDM subjects compared with Preg-Con subjects over time ( P = 0.025). Adipose tissue insulin receptor substrate (IRS)-1 protein levels were 43% lower ( P = 0.02) and p85α subunit of phosphatidylinositol 3-kinase was twofold higher ( P = 0.03) in GDM compared with Preg-Con subjects. The levels of peroxisome proliferator-activated receptor-γ (PPARγ) mRNA and protein were lower by 38% in Preg-Con ( P = 0.006) and by 48% in GDM subjects ( P = 0.005) compared with Non-Preg controls. Lipoprotein lipase and fatty acid-binding protein-2 mRNA levels were 73 and 52% lower in GDM compared with Preg-Con subjects ( P < 0.002). Thus GDM women have decreased IRS-1, which may contribute to reduced insulin suppression of lipolysis with advancing gestation. Decreased PPARγ and its target genes may be part of the molecular mechanism to accelerate fat catabolism to meet fetal nutrient demand in late gestation.Keywords
This publication has 48 references indexed in Scilit:
- PPARγ and the Treatment of Insulin ResistanceTrends in Endocrinology & Metabolism, 2000
- Uncoupling protein-2 (UCP2): Molecular and genetic studiesInternational Journal of Obesity, 1999
- Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.Journal of Clinical Investigation, 1997
- Uncoupling of Obesity from Insulin Resistance Through a Targeted Mutation in aP2 , the Adipocyte Fatty Acid Binding ProteinScience, 1996
- TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION DURING ADIPOCYTE DIFFERENTIATIONAnnual Review of Biochemistry, 1995
- The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.Journal of Clinical Investigation, 1995
- Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.Journal of Clinical Investigation, 1995
- Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 geneNature, 1994
- Prepregnancy Weight and Antepartum Insulin Secretion Predict Glucose Tolerance Five Years After Gestational Diabetes MellitusDiabetes Care, 1993
- Changes in skinfolds during pregnancyBritish Journal of Nutrition, 1967